Login to Your Account



Search

Search results

Pharma: Clinic Roundup

• Baxter International Inc. , of Deerfield, Ill., said it completed enrollment in its Phase III trial of BAX 855, an extended half-life recombinant Factor VIII treatment for hemophilia A. (BioWorld-Today-2013-11-14) ...

BioWorld Today - Staff - 2013-11-14 00:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Pfizer Inc. , of New York, said top-line results from a Phase IIb/IV study of Rapamune (sirolimus) evaluating kidney transplant patients who transitioned from tacrolimus (TAC)-based therapy to Rapamune three months to five months after transplant ...

BioWorld Today - Staff - 2013-11-11 00:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Boehringer Ingelheim GmbH , of Ingelheim, Germany, and Eli Lilly and Co. , of Indianapolis, reported data from a pooled analysis of 17 trials testing linagliptin in people with Type II diabetes and self-reported previous/current liver and biliar ...

BioWorld Today - Staff - 2013-11-08 00:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Shire plc , of Dublin, reported positive top-line results from two identically designed randomized placebo-controlled Phase III studies evaluating the efficacy and safety of Vyvanse (lisdexamfetamine dimesylate) capsules (CII) vs. placebo in adults ...

BioWorld Today - Staff - 2013-11-06 00:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Merck and Co. Inc. , of Whitehouse Station, N.J., said that in a Phase III study, its vaccine for human papilloma virus (HPV), V503, prevented 97 percent of cervical, vaginal and vulvar pre-cancers caused by HPV types 31, 33, 45, 52 and 58. ...

BioWorld Today - Staff - 2013-11-05 00:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Sunovion Pharmaceuticals Inc. , of Marlborough, Mass., published results from two pivotal trials supporting FDA approval of Latuda (lurasidone HCL) for major depressive episodes associated with bipolar I disorder in The American Journal of ...

BioWorld Today - Staff - 2013-11-04 00:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Lurasidone, an atypical antipsychotic developed by Dainippon Sumitomo Pharma Co. Ltd. , of Osaka, Japan, and marketed by its subsidiary Sunovion Pharmaceuticals Inc., of Marlborough, Mass., was the subject of five poster presentations at ...

BioWorld Today - Staff - 2013-10-14 23:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Merck & Co. Inc. , of Whitehouse Station, N.J., presented interim data from a Phase Ib trial of MK-3475, for non-small-cell lung cancer at the World Conference on Lung Cancer in Sydney. (BioWorld-Today-2013-10-30) ...

BioWorld Today - Staff - 2013-10-29 23:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Boehringer Ingelheim GmbH , of Ingelheim, Germany, presented data at the American College of Chest Physicians meeting in Chicago from Phase II and Phase III studies testing tiotropium in asthma. (BioWorld-Today-2013-10-29) ...

BioWorld Today - Staff - 2013-10-28 23:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Sihuan Pharmaceutical Holdings Group Ltd. , of Hong Kong, said the China Food and Drug Administration accepted its application for clinical trial approval of pirotinib. In preclinical studies, the second-generation inhibitor, aimed at the treatment ...

BioWorld Today - Staff - 2013-10-10 23:00 - 0 comments - 0 attachments